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Abstract: It is consensus in the metabolomics community that standardized protocols 
should be followed for sample handling, storage and analysis, as it is of utmost importance to 
maintain constant measurement conditions to identify subtle biological differences. The aim 
of this work, therefore, was to systematically investigate the influence of freezing procedures 
and storage temperatures and their effect on NMR spectra as a potentially disturbing aspect 
for NMR-based metabolomics studies. Urine samples were collected from two healthy 
volunteers, centrifuged and divided into aliquots. Urine aliquots were frozen either at −20 °C, 
on dry ice, at −80 °C or in liquid nitrogen and then stored at −20 C, −80 °C or in liquid 
nitrogen vapor phase for 1–5 weeks before NMR analysis. Results show spectral changes 
depending on the freezing procedure, with samples frozen on dry ice showing the largest 
deviations. The effect was found to be based on pH differences, which were caused by 
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variations in CO2 concentrations introduced by the freezing procedure. Thus, we recommend 
that urine samples should be frozen at −20 °C and transferred to lower storage temperatures 
within one week and that freezing procedures should be part of the publication protocol. 
Keywords: NMR; metabolomics; urine; freezing; storage; SOP; pH; dry ice; CO2 
 
1. Introduction 
The general aim of metabolomics studies is the identification of mostly subtle differences in 
biological systems under defined conditions. The detection of those subtle differences usually requires 
the maximum possible reproducibility of both sample preparation and measurement. The smallest 
changes in the sample treatment or analysis can confound the desired effects and lead to noise in 
corresponding data that adds to the underlying biological variations and complicates data interpretation. 
It is therefore necessary to study in detail every single step in a standard operating procedure (SOP) and 
eliminate potential disturbances. Practically all studies on biological systems involve freezing and 
storage steps, and freezing conditions may vary—even within a study—usually because of local 
conditions, like the accessibility or inaccessibility of a freezer in close proximity to the site where the 
samples are generated and the corresponding use of dry ice for freezing or intermediate storage at a 
certain floor, etc. Therefore, our aim was the detailed investigation of common freezing conditions and 
their effects on resulting NMR spectra using buffered urine as one of the most commonly studied 
biological matrices. 
NMR is widely used as an analytical technique in the field of metabolomics [1-3]. Often, it is applied 
as a non-targeted fingerprinting method, i.e., only the pattern of the metabolite spectra is analyzed rather 
than the identity and quantity of underlying compounds [1]. In these cases, the peak positions in the 
spectra are just as important as their intensities. For most detectable metabolites, this is not an issue, 
because their signals are not influenced by variations in the samples (e.g., hippurate), but roughly 
10%–20% of the compounds are sensitive towards pH or salt concentration changes (e.g., citrate, 
histidine (His) and its derivates [4,5]), which results in peak shifts. In this respect, urine is difficult to 
handle, as it shows large differences in pH and salt concentration between individuals, which is the 
reason why it is common practice to try to adjust the pH by adding a highly concentrated buffer [5-7]. 
Still, there are large inter-individual differences in urine composition, and even with a final 
concentration of 150 mM phosphate buffer, the pH of the resulting urine samples varies—in our 
experience, approximately between pH 6.8 and 7.2. Different strategies to account for these sample 
differences are applied, for example, using higher buffer concentrations [8] or adjusting the pH [9], but it 
is obvious that no further variations should be introduced by sample handling, storage or preparation. 
Although some basic studies have been published that investigated the influence of sample treatment 
and storage temperature on NMR-based urine metabolite profiles in the context of the interpretation of 
NMR-based urine metabolomics studies [8,10-12], the number of publications is limited, and some 
questions remain open. 
Based on principal component analysis (PCA) of binned NMR spectra, some authors have reported 
that there is no difference between samples stored at different temperatures for several months, as long 




as the samples are cooled to 4 °C or frozen at ≤ −20 °C [8,10]. Saude and Sykes looked at changes of a 
set of 55 predefined metabolites in urine samples that were pre-treated in different ways and stored at 
different temperatures for four weeks. They found no significant changes in metabolite concentrations over 
time when samples conserved with NaN3 were stored at −80 °C and only little changes in samples stored  
at 4 °C [11]. For these studies, it can only be speculated that urine samples were also frozen at the 
temperatures at which they were stored, since this information was not given. In fact, most publications 
in the field of metabolomics note only the storage temperature of the samples prior to analysis, but for 
practical reasons, the actual freezing procedure may require conditions that are different from long-term 
storage conditions. This influence of the freezing procedure on NMR spectra of urine samples has not 
been reported as such in the literature. Recently, Bernini et al. observed differences in urine NMR 
spectra depending on sample processing (centrifugation or not) and freezing/storage temperature [5]. In 
samples that were relatively slowly frozen and stored at −80 °C using a freezer, the difference between 
pre-centrifuged and non-pre-centrifuged samples was largest, while rapid freezing and storing samples 
in liquid nitrogen (lN2) resulted in only small differences between samples that were centrifuged or not [5]. 
Thus, snap freezing samples may be a useful solution, not only when working with tissues or cells, but 
also with biofluids that may contain some cells. In many laboratories, rapidly freezing samples can more 
easily be achieved with dry ice, which is solid carbon dioxide (CO2), but the influence of freezing urine 
on dry ice on the respective urine NMR spectra has never been reported. 
Therefore, the aim of this work was to test different combinations of practically relevant freezing 
procedures, including dry ice and storage temperatures of human urine samples, and to investigate their 
effect on NMR spectra in order to develop a SOP that is practicable in our hands and could be useful also 
for other scientists using NMR-based metabolomics on urine samples. 
2. Results and Discussion 
In order to investigate the influence of freezing and storage conditions on NMR spectra of human 
urine, a systematic screening was performed. Urine samples of two volunteers were centrifuged to 
eliminate bacteria or other cellular components [5], and supernatants were frozen at −20 °C, on dry ice 
(−78.5 °C), at −80 °C or in lN2 (−196 °C) and either analyzed after a few hours (―freezing‖) or stored at 
the same or a different temperature for one week before NMR measurement (―short-term storage‖) or 
stored at the same or a different temperature for an additional four weeks (―long-term storage‖) and 
analyzed thereafter (Scheme I). Samples that were not frozen, but kept at 4 °C for the same time as 
needed for freezing the samples, were used as a reference. Subsequently, standardized 1D 
1
H-NOESY 
NMR spectra with presaturation were acquired and processed uniformly for all samples, as described in 
the Experimental Section. In addition, several control experiments were performed to corroborate and 
extend the results described in the following subsections. 
2.1. Influence of Freezing and Storage Conditions on NMR Spectra of Urine Samples 
In general, NMR spectra of different aliquots of the same subject prepared independently at several 
occasions within five weeks are, as expected, very similar and again demonstrate the impressive 
reproducibility of NMR spectroscopy (Figure 1). However, closer inspection of the NMR spectra reveals 
that there are differences depending on the freezing procedure (Figure 1). Particularly in the aromatic 




region, marked peak shifts can be observed after freezing samples on dry ice or in a −80 °C freezer, the 
most prominent being the shift of the Hε1 peak of His at approximately 8.0 to 8.2 ppm, which shifts by 
about 0.04 to 0.06 ppm after freezing on dry ice, depending on the volunteer. Other peaks that show 
variations depending on the freezing procedure include the Hδ2 peak of His (7.1–7.2 ppm) and the 
corresponding peaks in His derivatives (1- or 3-methyl histidine, His dipeptides), but also creatinine 
(4.06 ppm) or citrate (2.7 ppm). These signals are known to be sensitive to pH changes [4,5]. The 
observed differences weakened or disappeared after a longer storage time, depending on the type of 
long-term storage (Figure 2). Whereas after storage of one or five weeks at −20 °C, the shifted  
His-Hε1-peak moved back to the same position as in the reference samples (not frozen) or samples that 
were frozen and stored at −20 °C, storage in lN2 conserved the state of the sample frozen in any 
condition over the five-week storage period. Interestingly, storage of urine samples at −80 °C introduced 
some unexpected variability in NMR spectra, and generally, variability between replicate NMR spectra 
was largest in samples frozen on dry ice. Remarkably, under all conditions where differences were 
observed, only the peak positions change, but not the intensity of the peaks, which means that there are 
no concentration changes of metabolites. In other words, the observed chemical shift variations due to 
different freezing or storage conditions are not caused by the decomposition of macromolecules or 
degradation of metabolites. Therefore, it can be assumed that the observed chemical shift changes can 
affect pattern recognition/fingerprinting analyses of resulting NMR spectra, but not a targeted 
quantitative evaluation of NMR data. 
To get an overview of the general variability of NMR spectra and in order to test if the observed 
changes indeed influence pattern recognition analyses, we have performed a PCA analysis. In a PCA of 
a single subject, only samples that were frozen on dry ice and either analyzed immediately or stored 
thereafter in lN2 are distinct from the others (not shown). When all the samples of the two subjects are 
analyzed together, as also observed by others [8,10,12], the inter-individual differences between urine 
samples are by far larger than the influence of the freezing procedure, but still, the samples frozen on dry 
ice and analyzed directly or stored in lN2 thereafter are distinct from all others (Figure 3). The bins 
driving this separation mainly belong to His and its derivates, which are known to be pH-sensitive. 
Therefore, in most cases, the result or interpretation of a metabolomics experiment will in practice not 
be affected by the freezing condition or storage temperature, with one exception: when freezing the fresh 
samples on dry ice, the changes in NMR spectra are so large that they can affect the PCA analysis. 
In order to mimic the (in-house) transport of frozen samples on dry ice, three aliquots of one urine 
sample were frozen at −20 °C for 15 h and then stored on dry ice for 1.5 h before thawing and NMR 
analysis. The NMR spectra of these ―transport‖ samples do not show the strong shift of the 
His-Hε1-peak and strongly resemble samples frozen at −80 °C (Figure 4). Thus, we conclude that 
already frozen samples are less influenced by subsequent storage on dry ice and transport of frozen 
samples on dry ice at least for short time periods seems to have little impact on urine samples. 
2.2. Influence of Freezing and Storage Conditions on pH of Urine Samples 
The aromatic proton peaks of His are known to be sensitive to changes in pH [4,5], and imidazole is 
used as a pH reference in NMR-based metabolomics [13]. Therefore, the observed differences in peak 
positions in NMR spectra (Figure 1) seem to be mainly based on pH variations that are introduced during 




the freezing and (short-term) storage conditions. To confirm this hypothesis, the pH was measured in 
some of the samples after the NMR experiment, i.e., with buffer added (Figure 5). Although the changes 
in pH are small, due to the added buffer, there are reproducible pH changes of about 0.05 to 0.1 pH units 
in the samples that were frozen on dry ice and analyzed immediately or stored thereafter in lN2. Thus, the 
recorded pH differences correlate with the peak shifts observed in the NMR spectra. 
Figure 1. NMR spectra of a spot urine sample of a female subject, frozen and stored under 
different conditions. Upper panel: overview of whole NMR spectra—urea and water region 
excluded—demonstrating overall good reproducibility. Lower panels: zoom into relatively 
constant regions and variable regions with shifted peaks. 
 
Samples are colored according to their initial freezing/storage condition: orange: not frozen, but stored at 4 °C; 
black: -20 °C; blue: dry ice; green: -80 °C; red: lN2 (vapor phase). 




Figure 2. Zoom into pH-sensitive region of NMR spectra of the 24 h urine of a male subject. 
Samples are colored according to their initial freezing/storage condition (for the legend, see 
Figure 1) and grouped according to their last storage condition. 
 
For samples that were measured after long-term storage, the short-term storage condition is indicated by line 
style: dotted: −20 °C; dashed: −80 °C; solid: lN2. Samples that were frozen on dry ice and analyzed 
immediately or stored in a lN2 tank thereafter show a strong left shift of the shown His-Hε1-peak; storage at  
-80 °C also leads to some shift. 




Figure 3. Principal component analysis (PCA) of 196 samples from the two volunteers 
frozen and stored under different conditions. Samples colored according to freezing 
temperature (for the legend, see Figure 1). Subjects are separated in the scores plot (left), but, 
also, samples frozen on dry ice are distinct from others. The loadings plot (right) shows the 
variables (bins) responsible for the separation. In the first two PCs > 96% of the variance in 
the data are explained. R2 = 0.976, Q2 = 0.959. 
 
Figure 4. Transport on dry ice. In order to simulate transport of frozen samples on dry ice, 
aliquots of the male 24 h urine sample were frozen at −20 °C for 15 h and then stored on dry 
ice for 1.5 h before NMR sample preparation. The position of the His-Hε1-peak still shifts 
slightly, but not more than in samples frozen at −80 °C. 
 




Figure 5. Effect of freezing on pH of urine samples. pH values were determined in buffered 
urine samples with a final concentration of 150 mM phosphate buffer after NMR experiments. 
Samples that were frozen on dry ice have a significantly different pH compared to all other 
samples of the same volunteer. N = 3, values given as the mean + SD; * p < 0.05 vs. all other 
samples of the same subject (one-way ANOVA). 
 
2.3. Changes in NMR Spectra and pH Depend on Storage Vial 
As we observed pH changes that perfectly correlate with measured chemical shift changes, we 
performed further experiments to determine the underlying cause of the observed variations. A 
maximum change in pH from 7.2 to 7.1 was observed predominantly for samples stored on dry ice, 
which is solid CO2. CO2 partially reacts with water to form carbonic acid or hydrogen carbonate, its 
respective anion. It is thus highly likely that the observed pH change was caused by dissolution of CO2 
rather than other changes caused by the low temperatures, such as sample composition or degradation. 
Since polypropylene (PP) is permeable for many gases, including CO2, and since we could think of no 
other source of acidification of the samples, we tried to test the hypothesis that CO2 permeation of PP 
vials is the cause for the observed pH change in the urine samples analyzed. Therefore, we used a third 
urine sample that was aliquoted into different PP cryo vials, screw cap glass vials or glass tubes, which 
were sealed gas-tight. Samples in each type of vial were frozen at −20 °C, on dry ice or at -80 °C for 
approx. 16 h to 2.5 days before sample preparation. NMR analysis of these urine samples showed again 
the previously observed peak shifts of the samples frozen in cryo vials on dry ice, but only small changes 
in NMR spectra of samples frozen in glass screw cap vials and practically no peak shifts in samples 
frozen in sealed glass tubes (Figure 6a). At the same time, the pH differences between the samples stored 
at different conditions were weaker in screw cap glass vials and absent in sealed glass tubes (Figure 6b). 
As observed in previous experiments, the reproducibility of NMR spectra is generally slightly less in 
samples frozen in a -80 °C freezer compared to -20 °C and even less in samples frozen on dry ice. The 
variability observed with samples stored in glass vials may result from non-uniform tightening of the 






















Figure 6. Influence of storage vial on NMR spectra and pH of urine samples frozen under 
different conditions. (a) Variable region of NMR spectra of urine samples frozen at different 
temperatures and in different PP cryo or glass vials, colored according to freezing condition. 
Black: −20 °C; blue: dry ice; green: −80 °C. (b) pH values of corresponding urine samples, 
colored according to freezing temperature (see above). N = 3, except D (n = 1–2), values 
given as the mean + SD. * p < 0.05 vs. all other samples of the same vial (two-way ANOVA) 
(there are no statistics for D, due to a low number of replicates). 
 
A: Nunc PP cryo vial; B: VWR PP cryo vial (white silicone washer); C: VWR PP cryo vial (red silicone 
O-ring); D: Brand Neolab PP cryo vial; F: glass screw cap vial; G: sealed glass tube. PP, polypropylene. 
2.4. Changes in pH Are Caused by CO2 
To prove whether storage under the above mentioned conditions leads to a measurable amount of 
CO2 or hydrogen carbonate in the solution, we employed infrared spectroscopy. Since most compounds 
of urine give rise to infrared absorption bands, which could impede the identification of the hydrogen 
carbonate band in the spectrum due to their high concentration, for this experiment, we used buffer 
samples instead. One point two milliliter cryo vials containing 1 mL of 10% NMR buffer, corresponding 
to the same final concentration as in prepared urine samples, were frozen overnight either at −20 °C, on 
dry ice or at −80 °C. A cryo vial with buffer with the original pH of 7.2 that was stored at 4 °C served as 




















immediately after FTIR spectroscopy, which revealed that the sample stored on dry ice had undergone a 
pH change to 6.9, while the pH of the other two remained unchanged. 
The IR spectra are displayed in Figure 7. While the two samples stored at −20 °C and −80 °C show no 
difference to the reference sample (the spectrum is devoid of a signal, due to ideal subtraction of water 
and buffer absorption bands), both positive (increase) and negative (decrease) changes of absorption can 
be seen in the region between 900 and 2,500 cm
−1
 for the sample stored on dry ice. The phosphate bands 
at 1,080 and 990 cm
−1
 decrease, giving rise to negative intensity, while the one at 1,160 cm
−1
 increases, 
all corresponding with a lower pH [14]. Furthermore, a positive band at 1,361 cm
−1
 can be discerned. 
Through comparison with a sample of 40 mM sodium hydrogen carbonate dissolved in the same buffer, 
this band could be identified as hydrogen carbonate, corresponding with an increased hydrogen 
carbonate concentration in the buffer. This proves—together with the positive band at 2,343 cm
−1
 
corresponding to CO2—that indeed CO2 is the cause of the observed pH changes. 
Figure 7. Attenuated Total Reflection Fourier-Transform Infrared Spectroscopy (ATR-FTIR) 
spectra of three buffer samples frozen overnight at −20 °C (black), −80 °C (green) or on dry ice 
(blue). A spectrum of buffer stored overnight at 4 °C was used as a reference and was 
subtracted from all other spectra. 
 
Assignment of IR-bands: 1, 2, 3: phosphate; 4: hydrogen carbonate; 5: CO2, *: residual water. 
Is it possible to estimate how much CO2 is dissolved in the samples? In the IR spectra, the phosphate 
band at 1,160 cm
−1
 partially overlaps with the hydrogen carbonate band, and it is extremely sensitive to 
pH changes in the range of 10
−2
 around its pKA value. This renders a precise integration of the hydrogen 
carbonate band difficult. Instead, we calculated a lower value for the amount of dissolved hydrogen 




carbonate from the observed pH change and the known buffer concentration using the 
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 is approximately 1, at 












. Thus, to shift the ratio from 1 to 2 in our samples, 25 mM H3O
+
-ions are necessary. They must 
come from the dissolution of CO2 and subsequent dissociation of the carbonic acid. Since carbonic acid 
is a weak acid, not all carbonic acid is dissociated, and we estimate that 25 mM concentration is just a 
lower estimate for the amount of dissolved CO2. 
The diffusion of CO2 into cryo vials and hydrogen carbonate formation in aqueous solutions with 
concomitant changes in pH is detected in NMR analyses, due to the simple sample preparation that 
preserves as much as possible of the original properties of the samples. Other techniques that are 
frequently used in metabolomics, such as mass spectrometry and gas or liquid chromatography, require 
more complicated sample preparation and include extraction with organic solvents, purification by solid 
phase extraction or derivatization of samples. The ionization behavior of samples, however, certainly 
depends on the pH or charge state of corresponding molecules. How far such techniques may be affected 
by pH differences in the raw samples will strongly depend on sample treatment and cannot be judged by 
the presented data. 
3. Experimental Section  
3.1. Materials 
KH2PO4 and KOH were from Merck (Darmstadt, Germany); trimethylsilyl propionic adic-d4 (TSP, 
98 atom% D), NaN3 and D2O (99.9 atom% D) were from Aldrich (Steinheim, Germany). All chemicals 
were analytical grade and used without further purification. 
Different 1.2 mL PP cryo vials with an internal thread were obtained from VWR (Bruchsal, 
Germany), Nunc or Brand (Neolab, Heidelberg, Germany). 
NMR tubes were from Wilmad (Rototec-Spintec GmbH, Griesheim, Germany). 
3.2. Volunteers, Sample Collection, Freezing and Storage 
Spot or 24 h urine samples were collected from two healthy volunteers (one female, one male), 
centrifuged at 3,000 rpm (~1,850 rcf) for 10 min at 4 °C in a Jouan CR 422 centrifuge to eliminate 
bacteria or other cellular components that could disintegrate during freezing [5] and aliquoted into PP 
cryo vials (VWR). Urine aliquots were frozen for several hours, either at −20 °C, on dry ice, at −80 °C or 
in lN2, and then either analyzed by NMR directly or stored at −20 °C, −80 °C or in the lN2 vapor phase 
for 1–5 weeks (Scheme I). An additional 24 h urine sample collected from a third volunteer (female) was 
centrifuged as described above and aliquoted into four different types of PP cryo vials, screw cap glass 
vials or glass tubes that were sealed gas-tight. The samples in the different vials were then frozen and 




stored overnight either at −20 °C, on dry ice or at −80 °C. Volunteers were part of a larger study that is 
being conducted at the Max Rubner-Institut in Karlsruhe. The study protocol was approved by the 
Ethical Committee of the State Medical Chamber Baden-Württemberg, Germany (F-2011-051).  
All participants gave written consent prior to the study. 
Scheme I: Study design: two urine samples were each divided into 99 aliquots and frozen 
(or not) at different temperatures/conditions. Thereafter, samples were either left at the same 
temperature for short- or long-term storage or moved to a different short- or long-term 
storage temperature, as shown by the arrows. N = 3 for each condition. 
 
3.3. Sample Preparation and NMR Analysis 
For NMR analysis, thawed urine samples were mixed by inverting them 8–10 times, centrifuged at 
4,000 rpm (~3,300 rcf) for 10 min at 20 °C in a Jouan CR 422 centrifuge to remove any non-soluble 
particles and 540 µL of the supernatants were mixed with 60 µL NMR buffer (1.5 M KH2PO4, 2 mM 
NaN3, 0.1% TSP in D2O, pH 7.1), transferred to a 5 mm NMR tube (Wilmad) and measured in a Bruker 
Avance III 600 MHz NMR spectrometer equipped with a TCI inversely detected cryoprobe (Bruker 
BioSpin GmbH, Rheinstetten, Germany) at 300 K (27.1 °C) using a 1D NOESY experiment with 
presaturation for water suppression. A prescan delay of 4 s was used together with a mixing time of 10 ms. 
Pulse lengths were determined automatically by the Bruker AU program, pulsecal. 64k complex data 
points corresponding to a sweep width of 12,345.6 Hz were recorded. All spectra were treated 
identically using an exponential apodization function, introducing an additional linewidth of 0.3 Hz and 
automated phasing, baseline correction and referencing using the Bruker macro, apk0.noe. Each sample 
was analyzed in triplicate using independently prepared samples. 
3.4. Sample Preparation and Attenuated Total Reflection Fourier-Transform Infrared Spectroscopy 
(ATR-FTIR) 
Cryo vials containing 1 mL diluted (10%) NMR buffer, pH 7.2, were frozen and stored overnight on 
dry ice, at −20 °C or at −80 °C, respectively (2 samples per storage condition). A buffer sample stored 
overnight at 4 °C served as the reference. 




A Bruker Tensor 27 Fourier Transform IR spectrometer (Bruker Optik GmbH, Ettlingen, Germany), 
with a Bruker Bio ATR 2
®
 cell was employed to obtain the IR spectra of these samples. The special 
design of the cell provides constant temperature control of the sample solutions. The spectra were 
measured at 25 °C. The vials were inverted several times before the solution was applied to the 
measurement cell. Samples were allowed to temperature equilibrate for 2 minutes prior to measurement. 
The used ATR cell was equipped with an ATR crystal made from silicon with nine reflections, 64 scans 
in the 4,000–850 cm
−1
 spectral range were recorded on a photovoltaic MCT-detector with a scanner 
velocity of 20 kHz and a spectral resolution of 4 cm
−1
. The reference spectra were taken with the buffer 
solution stored at 4 °C before measurement. For data acquisition and evaluation, the Bruker OPUS
®
 
software, version 5.5, was used. 
3.5. pH Measurements 
In some urine samples, pH was measured after the NMR experiments using a Schott portable 
pH-meter with an InLab
®
 Expert Pro microelectrode. After the ATR-FTIR measurement, the pH of all 
buffer samples was measured with the same instrument that was calibrated with three reference solutions 
prior to the measurement. 
3.6. Data Analysis 
NMR spectra were displayed and analyzed using AMIX 3.9.10 (Bruker BioSpin GmbH, Rheinstetten, 
Germany). For the PCA, 196 NMR spectra were binned to 0.04 ppm in the region of 0.5–9 ppm, with the 
water and urea peaks excluded (6.0–4.5 ppm), yielding 177 bins, un-normalized bins were scaled to unit 
variance and the first 4 PCs were calculated, with PC1 and PC2 explaining > 96% of variance. 
For the statistical tests on pH values of urine samples, a one-way and two-way ANOVA was 
performed, respectively, using SigmaPlot 11.0 (Systat Software GmbH, Erkrath, Germany). 
4. Conclusions 
In metabolomics studies, often subtle changes need to be detected in order to find physiologically 
relevant differences between study groups. Every step along the way, from sample collection to data 
analysis, needs to be carefully controlled, and there are many efforts to standardize protocols and 
reporting them, e.g., for sample collection and storage [15]. The actual freezing procedure, however, has 
not been addressed so far, and indeed, in most publications in the field of metabolomics, the  
freezing condition of samples is not mentioned. However, although for practical reasons, the actual  
freezing procedure of collected samples may involve conditions (e.g., temperature) that are different  
from long-term storage, there are only a few examples in the literature where freezing conditions are  
given [16-18]. In this work, we have systematically screened different freezing conditions and storage 
temperatures of human urine samples and investigated their effects on the metabolic fingerprint of 
samples analyzed by NMR. 
Although the overall reproducibility of NMR is remarkable over the more than five weeks studied, we 
have observed differences in certain areas of the NMR spectra that indicate that some metabolites are 
affected by the freezing conditions. In some cases (for example His and derivates), this effect was large 




enough to potentially affect the results of a metabolomics study based on PCA. While freezing samples 
on dry ice showed the strongest effect, freezing and/or storage at −80 °C also induced changes in NMR 
spectra. These changes were found to be caused by changes in pH (acidification) that are, in turn, caused 
by an increase in CO2 and hydrogen carbonate in the sample, due to diffusion of CO2 through PP storage 
vials. In contrast, samples frozen in glass screw cap vials or sealed glass tubes did not show similar 
changes. The diffusion of CO2 into PP cryo vials while freezing samples on dry ice can easily be 
explained, since dry ice is solid CO2 and PP is known to be permeable for CO2. Using FTIR 
spectroscopy, we have shown an increase in CO2 and hydrogen carbonate concentration by at least 25 mM 
in buffer samples frozen on dry ice. Besides the effect for dry ice, we also have observed small, but 
unambiguously measurable, chemical shift changes for urine samples frozen or stored at −80 °C, 
affecting the same pH-dependent NMR signals. However, the effect seems to be variable and is not as 
well reproducible as the effects seen for dry ice. We can only speculate about the cause of the latter 
observation: the freezing temperature of CO2 is −78.5 °C, so it can be assumed that some CO2 from the 
air will solidify in a −80 °C freezer, eventually leading to some amount of dry ice. Depending on the 
intensity of use of the freezer and the inside temperature, which typically varies between −76 °C and −82 °C, 
it could be possible that the atmosphere inside a −80 °C freezer is at times enriched with CO2 compared 
to the normal room air or to a −20 °C freezer. This could also explain the here observed variability of 
NMR spectra of samples frozen or stored at −80 °C, which was always slightly larger than in samples 
frozen or stored at −20 °C or in lN2. Unfortunately, we were not able to measure directly the CO2 
concentrations inside our −80 °C freezer, and we did not see changes in CO2 or hydrogen carbonate 
concentrations in the few buffer samples frozen at −80 °C. We, therefore, cannot fully exclude that also 
other mechanisms besides the pH change due to an increased CO2-level may contribute to the 
variability in urine samples frozen and stored at −80 °C. In all cases, the sources of variability described 
by Bernini et al. [5] are not likely to contribute to the observed variations, since their protocol of 
pre-centrifuging urine samples before freezing was followed to avoid breaking of cells and since 
chemical reactions, bacterial growth or enzymatic reactions should take place in all samples alike and have 
been described to lead to an alkalinization of urine samples in contrast to the acidification observed here. 
Although it may be argued that urine from 24 h collections are usually frozen directly in the 
long-term storage device, local conditions or study design—such as in our own study center—still might 
make it necessary to use a different freezing procedure for short-term intermediate storage with the very 
same preconditions as described here. 
Also, we have investigated urine from only two persons. This, however, is only a problem as long as 
statistic features are studied. In the present study, instead, we give a defined cause to the observed changes in 
spectra and consolidate the findings with further samples and with three different types of measurements, 
which all lead to the same coherent conclusion that CO2 is the cause of the observed pH changes. 
The changes observed in this study may not be a problem in targeted/quantitative analyses of NMR 
spectra, where peaks are annotated to a metabolite and integrated for quantification, and the exact peak 
position is not as relevant. On the other hand, the described changes can easily be avoided by carefully 
choosing the freezing and storage conditions. Based on the results of this study, it seems that dry ice 
cannot be recommended to freeze samples, unless all samples are treated in the same way, but dry ice 
should have little effect during short transport periods of already frozen samples. 




Thus, we would recommend that, if freezing samples in lN2 is not feasible, urine samples should be 
frozen at −20 °C and transferred to lower storage temperatures (−80 °C, lN2) within one week. If this is 
not possible, all samples of a study should be frozen in the same way. Finally, independent of the 
protocol applied, the freezing procedure should be part of every metabolomics publication. 
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